When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRK - Novocure teams up with Merck in lung cancer study
Merck & Company Inc.
Novocure (NASDAQ:NVCR) will collaborate with Merck (NYSE:MRK) on a Phase 2 pilot study evaluating the concomitant use of Tumor Treating Fields and Keytruda (pembrolizumab) in PD-L1-positive non-small cell lung cancer (NSCLC) patients in a first-line setting.
More news on: NovoCure Limited, Merck & Co., Inc., Healthcare stocks news,